Acta Scientific Medical Sciences (ISSN: 2582-0931)

Research Article Volume 4 Issue 6

Interest of Screening and Management for Sleep Disorders in the Drug-Resistant Depressive Syndrome

Sandrine Pradel-Neuman and Eric Neuman*

CMPI, Le Vésinet, France

*Corresponding Author: Eric Neuman, CMPI, Le Vésinet, France

Received: February 17, 2020; Published: May 11, 2020



 During the last two years, in a multidisciplinary psychiatric practice, a psychiatrist assisted with a sleep therapist decided to demonstrates that the management of secondary insomnia (induced by sleep apnea/hypopnea syndrome (SAHS)) and some other primary sleep disorders, with specific sleep therapy can reduce or sometimes even stop antidepressant treatments when a welldefined protocol is followed. Their results confirmed that in some of their patients there may be SAHS in drug-resistant depressions. This point out the fact any depression syndromes are due to or aggravated by insomnia induced by SAHS. Taking care of it may replace antidepressants.

Keywords: Sleep Disorders; Depressive Syndrome; Drug Resistance



  1. Ejaz SM., et al. “Obstructive Sleep Apnea and Depression. A Review”. Innovations in Clinical Neuroscience 8 (2011): 17-25.
  2. Harris M., et al. “Obstructive sleep apnea and depression”. Sleep Medicine Reviews6 (2009): 437-444.
  3. Schröder CM and O'Hara R. “Depression and Obstructive Sleep Apnea (OSA)”. Annals of General Psychiatry 4 (2005): 13.
  4. Beck L., et al. “Sleep disorders: Sociodemographics and psychiatric comorbidities in a sample of 14,734 adults in France (Baromètre santé INPES)”. Revue Neurologique11 (2009): 933-942.
  5. Gharsalli H., et al. “Caractéristique des patients SAOS dépressifs”. Médecine du Sommeil1 (2019): 45.
  6. Mollo JL. “Insomnie et syndrome d’apnée obstructive du sommeil: liaison dangereuse”. Médecine du Sommeil4 (2014): 197-205.
  7. Royant-Parola S. “Depression et SAS: une intrication sans fin; Depression and sleep apnéea syndrome an endless entanglement”. Médecine du Sommeil1 (2013): 29-31.
  8. Royant -Parola S. “Depression et troubles cognitifs dans le SAS; Depression and cognitive disorders en SAS”. Revue des Maladies Respiratoires2 (2006): 94-96.
  9. Chalumeau F. “SAOS de l’Adulte: Les Explorations du Sommeil par PGV et PSG”. La lettre d’Oto-rhino-larymgologie et de Chirurgie (2012).
  10. Launois S and Rey M. “Place des différents enregistrements au cours du sommeil: résumé du rapport de l’évaluation de l’HAS. Practice guidelines for the various sleep recordings, summary of HAS evaluation report”. Médecine du Sommeil1 (2013): 6-11.
  11. Bahammam AS., et al. “Comorbid depression in obstructive sleep apnea: an under-recognized association”. Sleep Breath 2 (2016): 447-456.
  12. Fresco JP., et al. “Somnolence diurne excessive et dépression: données polysomnographiques. Excessive daytime sleepimen and depression polysomnographical data”. Médecine du Sommeil1 (2013): 19-28.
  13. Leclair-Visonneau L., et al. “Comment poser le diagnostic d’un syndrome des jambes sans repos? How to diagnose restless legs syndrome?” Médecine du Sommeil2 (2019): 97-105.
  14. Limousin N., et al. “Traitement du syndrome des jambes sans repos nouvellement diagnostiqué; Treatment of newly diagnosed restless legs syndrome”. Médecine du Sommeil2 (2019): 106-113.
  15. Micoulaudet JA., et al. “Réalization and interpretation of sleep exploration for sleep disorders with mental disorders comorbidities”. Annales Médico-psychologiques, Revue Psychiatrique5 (2019): 468-482.
  16. Neuman E and Neuman-Pradel S. “Mes nuits sans sommeil, tout comprendre sur l’insomnie; my nights without sleeping, all understand about insomnia”. Editions Grégo-Vernazobres, Paris (2017): 190.


Citation: Sandrine Pradel-Neuman and Eric Neuman. “Interest of Screening and Management for Sleep Disorders in the Drug-Resistant Depressive Syndrome". Acta Scientific Medical Sciences 4.6 (2020): 32-36.


Acceptance rate30%
Acceptance to publication20-30 days
Impact Factor1.403

Indexed In

News and Events

Contact US